340B 360
340B 360
Podcast Description
340B 360°, a new podcast from 340B Report, is your exclusive window into the industry leaders that provide products and services to hospitals, community health centers and other 340B providers to help them implement and comply with the 340B drug pricing program. Each episode, posted monthly, provides a special opportunity to get to know the C-suite executives of 340B Report’s impressive group of sponsors, the valuable expertise they provide, and their insights on key developments in this critically important drug discount program.
Podcast Insights
Content Themes
The podcast focuses on key themes such as compliance challenges, leadership in the healthcare industry, and innovations within the 340B program. For example, the first episode discusses adapting to 340B changes with Verity Solutions' CEO, covering topics like contract pharmacy restrictions and the importance of transparency in showcasing how 340B savings are utilized to enhance patient care. Other episodes may address topics like revenue generation and efficiency in healthcare technology.
340B Leaders Upfront is your exclusive window into the industry leaders that provide products and services to hospitals, community health centers and other 340B providers to help them implement and comply with the 340B drug pricing program. Each episode, posted monthly, provides a special opportunity to get to know the C-suite executives of 340B Report’s impressive group of sponsors, the valuable expertise they provide, and their insights on key developments in this critically important drug discount program.
In this episode of our business podcast 340B Leaders Upfront, host Anna Mangum sits down with Melissa Opraseuth, Chief Clinical Officer at NuvemRx. Founded in 2013 as 340B Basics and rebranded as NuvemRx in 2023 to reflect a broader mission, the firm offers solutions in pharmacy management, 340B technology and compliance customized for community health centers.
Key Topics Covered:
Journey to 340B
Melissa shares formative experiences that inspired her to pursue a career in pharmacy,, including how healthcare technology innovations and other supports were critically important for a disabled family member. She outlines her experience in direct patient care, medical affairs at two drug companies, entrepreneurship, and executive leadership.
Referral Capture from Specialist Visits
Melissa provides background on the company that she worked for before it was acquired by NuvemRx earlier this year that specializes in referral capture. She highlights how this service is unlocking 340B savings that community health center clients are investing in a variety of programs to serve vulnerable patients, such as addressing pediatric dental “deserts” and helping with transportation needs.
Responding to Claims Data Requirements
Melissa provides an overview of how clients are leveraging NuvemRx’ platform to respond to drug manufacturers’ increasing claims data requirements. She describes the advantage of deploying NuvemRx’ synergistic platform, which supports the full dispensing footprint, including in-house, contract and specialty pharmacy, versus managing disparate platforms.
Career Directions in 340B Services
Melissa describes current and emerging career opportunities in the 340B services space, including in technology. She emphasizes the importance of consistently honing a strong understanding of covered entity operations, and of seeking input and guidance from 340B peers.
Follow our Podcasts
Stay tuned for more episodes of 340B Leaders Upfront, which are posted monthly! Subscribe to 340B Leaders Upfront on your favorite podcast platform or YouTube.
Bonus: Listen to Inside 340B Report, our twice-monthly podcast, to get a behind-the-scenes window into the latest 340B news and developments from the journalists at 340B Report.
Special Offer for New 340B Report Subscribers
First-time subscribers to 340B Report can use code PODCAST25 for 25% off when subscribing. Or contact us for a free 15-day trial to see why 340B Report is the indispensable source for 340B news and intelligence.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.